Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbon nanoparticles as lymph node tracer and cisplatin delivery during radical lung cancer surgery
ChiCTR-IPR-15007367Phase 4Completed
- Sponsor
- Yunnan Cancer Hospital
- Start
- Jun 2011
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of cisplatin and carbon nanoparticles in bronchial carcinoma (3 arms), sponsored by Yunnan Cancer Hospital. Primary endpoints: Number of dissected lymph nodes, Number of metastatic lymph nodes and 7 more. Started Jun 2011; status: completed.
02
Drugs
cisplatincarbon nanoparticles
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR-IPR-15007367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007367.